grant

Control of antiviral memory CD8+ T cell longevity by extracellular ATP sensing

Organization MAYO CLINIC ARIZONALocation SCOTTSDALE, UNITED STATESPosted 1 Jul 2022Deadline 30 Jun 2027
NIHUS FederalResearch GrantFY2025AddressAffectAnti-viral TherapyAntibodiesAutoregulationBody TissuesCD8CD8 CellCD8 T cellsCD8 lymphocyteCD8+ T cellCD8+ T-LymphocyteCD8-Positive LymphocytesCD8-Positive T-LymphocytesCD8BCD8B1CD8B1 geneCRISPR approachCRISPR based approachCRISPR methodCRISPR methodologyCRISPR techniqueCRISPR technologyCRISPR toolsCRISPR-CAS-9CRISPR-based methodCRISPR-based techniqueCRISPR-based technologyCRISPR-based toolCRISPR/CAS approachCRISPR/Cas methodCRISPR/Cas technologyCRISPR/Cas9CRISPR/Cas9 technologyCas nuclease technologyCell BodyCell Communication and SignalingCell DeathCell SignalingCell SurvivalCell ViabilityCellsCirculationClustered Regularly Interspaced Short Palindromic Repeats approachClustered Regularly Interspaced Short Palindromic Repeats methodClustered Regularly Interspaced Short Palindromic Repeats methodologyClustered Regularly Interspaced Short Palindromic Repeats techniqueClustered Regularly Interspaced Short Palindromic Repeats technologyComplementComplement ProteinsComplexCuesDataDevelopmentDiseaseDisorderEffector CellFocal InfectionFutureGenerationsGeneticGoalsGrippeHomeostasisImmune responseImmunityImmunizationIncrease lifespanInfectionInflammationInflammatoryInfluenzaInfluenza VirusInnate ImmunityIntracellular Communication and SignalingKnock-outKnockoutKnowledgeLYT3Length of LifeLongevityLungLung ParenchymaLung Respiratory SystemLung TissueLung damageMapsMediatingMedicalMemoryNative ImmunityNatural ImmunityNon-Specific ImmunityNonspecific ImmunityPathway interactionsPersonsPhysiological HomeostasisPopulationReceptor ProteinRegulationReporterReportingRoleRouteSignal TransductionSignal Transduction SystemsSignalingStructure of parenchyma of lungSystemic infectionT8 CellsT8 LymphocytesTestingTimeTissuesUnited StatesUpregulationVaccinesViralViral DiseasesVirusVirus Diseasesadaptive immunityanti-viral immunityantiviral immunitybiological signal transductionboost longevitycomplementationcytotoxic CD8 T cellscytotoxic CD8 T lymphocytedesigndesigningdevelopmentalelongating the lifespanenhance longevityexperimentexperimental researchexperimental studyexperimentsextend life spanextend lifespanextend longevityextracellularfluflu infectionflu serotypeflu strainflu subtypeflu viral strainflu virus infectionflu virus strainfoster longevityhost responseimmune system responseimmunoresponseimprintimprove lifespanimprove longevityinfected with fluinfected with flu virusinfected with influenzainfected with influenza virusinfection localizedinfluenza infectioninfluenza serotypeinfluenza straininfluenza subtypeinfluenza viral straininfluenza virus infectioninfluenza virus straininfluenzavirusinterestlifespan extensionlocal infectionlung injurynecrocytosisoverexpressoverexpressionpathwayprolong lifespanprolong longevitypromote lifespanpromote longevitypulmonary damagepulmonary injurypulmonary tissue damagepulmonary tissue injuryreceptorresponsesecondary lymph organsecondary lymphatic organsecondary lymphoid organsensorsocial rolesupport longevitytoolviral infectionviral infectious disease treatmentvirus infectionvirus-induced disease
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Full Description

Project summary: Development of long-lived memory CD8+ T cells is paramount for the control of viral
infections, such as influenza. The complete identification of extracellular factors promoting memory CD8+ T

cells will favor the better design of CD8+ T cell-inducing immunizations and antiviral therapies. Notably, we

have found that one of these factors, extracellular ATP (eATP) – via its receptor P2RX7 - promotes the

generation and long-term survival of virus-specific memory CD8+ T cells, both in the circulation (central

memory cells – TCM) and in barrier tissues (resident memory cells – TRM) in response to systemic viral infection.

These findings highlight an unanticipated role for the “danger signal” eATP for the promotion of antiviral

immunity. However, there still are gaps on the understanding of how P2RX7 promotes memory CD8+ T cell

long-term survival. This is especially true for the TRM pool, which is relevant both in the context of both systemic

and tissue-localized infections. In Aim 1, we will build up on preliminary studies suggesting that P2RX7

upregulation in a subset of memory precursors favor the development of long-lived TRM cells. We are especially

interested in understanding how preferential upregulation of P2RX7 at such an early stage of the immune

response affects TRM cell survival long after this time window. In Aim 2, we propose to address how P2RX7

expression promotes TRM cell longevity in the context of influenza infection. Our preliminary data suggests that,

despite initial seeding of the lung is mostly independent of P2RX7 (and expression of P2RX7 itself is low),

influenza-specific lung TRM cells that survive the numerical decay typical of this infection express high levels of

P2RX7, and need this receptor to maintain. We will perform experiments to understand (a) the origin of

P2RX7-expressing long-lived flu-specific lung TRM cells, and (b) how manipulating P2RX7 expression and its

potential upstream regulation promote better survival of lung TRM cells and their protective ability against

secondary influenza challenge. Overall, we will test the hypothesis that, in response to multiple viral infections,

expression of the eATP sensor P2RX7 selects memory CD8+ T cells for long-term survival in barrier tissues.

These studies will establish how dynamic regulation of this eATP sensor promotes the longevity of memory

CD8+ T cells in distinct infection and inflammatory contexts. They will also serve as a proof-of-concept for

potential future experimental setups aiming to boost the protective ability of memory CD8+ T cells to influenza,

a disease of high medical relevance.

Grant Number: 5R01AI170649-04
NIH Institute/Center: NIH

Principal Investigator: Henrique Borges da Silva

Sign up free to get the apply link, save to pipeline, and set email alerts.

Sign up free →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →